Your browser doesn't support javascript.
loading
Psychosis Endophenotypes: A Gene-Set-Specific Polygenic Risk Score Analysis.
Wang, Baihan; Irizar, Haritz; Thygesen, Johan H; Zartaloudi, Eirini; Austin-Zimmerman, Isabelle; Bhat, Anjali; Harju-Seppänen, Jasmine; Pain, Oliver; Bass, Nick; Gkofa, Vasiliki; Alizadeh, Behrooz Z; van Amelsvoort, Therese; Arranz, Maria J; Bender, Stephan; Cahn, Wiepke; Stella Calafato, Maria; Crespo-Facorro, Benedicto; Di Forti, Marta; Giegling, Ina; de Haan, Lieuwe; Hall, Jeremy; Hall, Mei-Hua; van Haren, Neeltje; Iyegbe, Conrad; Kahn, René S; Kravariti, Eugenia; Lawrie, Stephen M; Lin, Kuang; Luykx, Jurjen J; Mata, Ignacio; McDonald, Colm; McIntosh, Andrew M; Murray, Robin M; Picchioni, Marco; Powell, John; Prata, Diana P; Rujescu, Dan; Rutten, Bart P F; Shaikh, Madiha; Simons, Claudia J P; Toulopoulou, Timothea; Weisbrod, Matthias; van Winkel, Ruud; Kuchenbaecker, Karoline; McQuillin, Andrew; Bramon, Elvira.
Afiliação
  • Wang B; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • Irizar H; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Thygesen JH; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • Zartaloudi E; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Austin-Zimmerman I; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • Bhat A; Institute of Health Informatics, University College London, London, UK.
  • Harju-Seppänen J; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • Pain O; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • Bass N; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Gkofa V; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • Alizadeh BZ; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • van Amelsvoort T; Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Arranz MJ; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • Bender S; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • Cahn W; University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Rob Giel Research Center, Groningen, The Netherlands.
  • Stella Calafato M; Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.
  • Crespo-Facorro B; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Di Forti M; Fundació Docència i Recerca Mutua Terrassa, Terrassa, Spain.
  • Giegling I; Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • de Haan L; Department of Psychiatry, Brain Centre Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Hall J; Altrecht, General Mental Health Care, Utrecht, The Netherlands.
  • Hall MH; Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK.
  • van Haren N; CIBERSAM, Centro Investigación Biomédica en Red Salud Mental, Sevilla, Spain.
  • Iyegbe C; Department of Psychiatry, University Hospital Virgen del Rocio, School of Medicine, University of Sevilla-IBiS, Sevilla, Spain.
  • Kahn RS; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Lawrie SM; Comprehensive Centers for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Austria.
  • Lin K; Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Luykx JJ; Arkin, Institute for Mental Health, Amsterdam, The Netherlands.
  • Mata I; Neuroscience and Mental Health Innovation Institute, School of Medicine, Cardiff University, Hadyn Ellis Building, Mandy Road, Cardiff, UK.
  • McDonald C; Psychosis Neurobiology Laboratory, Harvard Medical School, McLean Hospital, Belmont, MA, USA.
  • McIntosh AM; Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Center, Sophia's Children Hospital, Rotterdam, The Netherlands.
  • Murray RM; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Picchioni M; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Powell J; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
  • Prata DP; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Rujescu D; Department of Psychiatry, Brain Centre Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Rutten BPF; Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Shaikh M; Fundacion Argibide, Pamplona, Spain.
  • Simons CJP; CIBERSAM, Centro Investigación Biomédica en Red Salud Mental, Madrid, Spain.
  • Toulopoulou T; The Centre for Neuroimaging & Cognitive Genomics (NICOG) and NCBES Galway Neuroscience Centre, University of Galway, Galway, Ireland.
  • Weisbrod M; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
  • van Winkel R; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
  • Kuchenbaecker K; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Bramon E; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Schizophr Bull ; 49(6): 1625-1636, 2023 11 29.
Article em En | MEDLINE | ID: mdl-37582581
ABSTRACT
BACKGROUND AND

HYPOTHESIS:

Endophenotypes can help to bridge the gap between psychosis and its genetic predispositions, but their underlying mechanisms remain largely unknown. This study aims to identify biological mechanisms that are relevant to the endophenotypes for psychosis, by partitioning polygenic risk scores into specific gene sets and testing their associations with endophenotypes. STUDY

DESIGN:

We computed polygenic risk scores for schizophrenia and bipolar disorder restricted to brain-related gene sets retrieved from public databases and previous publications. Three hundred and seventy-eight gene-set-specific polygenic risk scores were generated for 4506 participants. Seven endophenotypes were also measured in the sample. Linear mixed-effects models were fitted to test associations between each endophenotype and each gene-set-specific polygenic risk score. STUDY

RESULTS:

After correction for multiple testing, we found that a reduced P300 amplitude was associated with a higher schizophrenia polygenic risk score of the forebrain regionalization gene set (mean difference per SD increase in the polygenic risk score -1.15 µV; 95% CI -1.70 to -0.59 µV; P = 6 × 10-5). The schizophrenia polygenic risk score of forebrain regionalization also explained more variance of the P300 amplitude (R2 = 0.032) than other polygenic risk scores, including the genome-wide polygenic risk scores.

CONCLUSIONS:

Our finding on reduced P300 amplitudes suggests that certain genetic variants alter early brain development thereby increasing schizophrenia risk years later. Gene-set-specific polygenic risk scores are a useful tool to elucidate biological mechanisms of psychosis and endophenotypes, offering leads for experimental validation in cellular and animal models.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Transtorno Bipolar Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Transtorno Bipolar Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article